Dwight D. Stiff

525 total citations
18 papers, 444 citations indexed

About

Dwight D. Stiff is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Dwight D. Stiff has authored 18 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Dwight D. Stiff's work include Pharmacogenetics and Drug Metabolism (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Analytical Chemistry and Chromatography (3 papers). Dwight D. Stiff is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Analytical Chemistry and Chromatography (3 papers). Dwight D. Stiff collaborates with scholars based in United States and Egypt. Dwight D. Stiff's co-authors include Reginald F. Frye, Michael A. Zemaitis, Robert A. Branch, Maged H. M. Sharaf, Adedayo Adedoyin, David C. Smith, Roger Day, D L Trump, LaDonna Immken and Larry Dolan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Life Sciences and Pharmacology Biochemistry and Behavior.

In The Last Decade

Dwight D. Stiff

18 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dwight D. Stiff United States 13 158 121 71 69 55 18 444
Stanley R. Howell United States 11 151 1.0× 118 1.0× 38 0.5× 46 0.7× 53 1.0× 20 452
Bindhu V. Karanam United States 14 249 1.6× 95 0.8× 63 0.9× 92 1.3× 41 0.7× 23 583
Donald W. Everett United States 11 162 1.0× 177 1.5× 118 1.7× 122 1.8× 18 0.3× 12 753
Su-Er W. Huskey United States 11 133 0.8× 194 1.6× 56 0.8× 127 1.8× 34 0.6× 13 548
M. Volz Germany 10 150 0.9× 49 0.4× 64 0.9× 45 0.7× 46 0.8× 24 422
Gregory M. Kochak Switzerland 12 76 0.5× 89 0.7× 105 1.5× 77 1.1× 68 1.2× 34 483
Anne Wu United States 13 206 1.3× 43 0.4× 84 1.2× 78 1.1× 47 0.9× 19 651
L. Bardou France 11 114 0.7× 134 1.1× 37 0.5× 39 0.6× 28 0.5× 24 413
Roeline Jochemsen France 9 99 0.6× 93 0.8× 59 0.8× 141 2.0× 12 0.2× 12 496
H Kinoshita Japan 16 124 0.8× 219 1.8× 59 0.8× 254 3.7× 32 0.6× 51 591

Countries citing papers authored by Dwight D. Stiff

Since Specialization
Citations

This map shows the geographic impact of Dwight D. Stiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwight D. Stiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwight D. Stiff more than expected).

Fields of papers citing papers by Dwight D. Stiff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwight D. Stiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwight D. Stiff. The network helps show where Dwight D. Stiff may publish in the future.

Co-authorship network of co-authors of Dwight D. Stiff

This figure shows the co-authorship network connecting the top 25 collaborators of Dwight D. Stiff. A scholar is included among the top collaborators of Dwight D. Stiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwight D. Stiff. Dwight D. Stiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stiff, Dwight D., et al.. (2010). Pharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tablet. Expert Opinion on Pharmacotherapy. 11(5). 701–708. 19 indexed citations
2.
Stiff, Dwight D., et al.. (2009). Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers. Current Medical Research and Opinion. 25(10). 2423–2428. 10 indexed citations
3.
Sharaf, Maged H. M. & Dwight D. Stiff. (2004). Determination of guaifenesin in human serum by capillary gas chromatography and electron capture detection. Journal of Pharmaceutical and Biomedical Analysis. 35(4). 801–806. 27 indexed citations
4.
Frye, Reginald F., Dwight D. Stiff, & Robert A. Branch. (1998). A Sensitive Method for the Simultaneous Determination of Caffeine and its Dimethylxanthine Metabolites in Human Plasma: Application to CYP1A2 Phenotyping. Journal of Liquid Chromatography & Related Technologies. 21(8). 1161–1171. 16 indexed citations
5.
Adedoyin, Adedayo, Dwight D. Stiff, David C. Smith, et al.. (1997). All- trans -retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes. Cancer Chemotherapy and Pharmacology. 41(2). 133–139. 24 indexed citations
6.
Trump, D L, David C. Smith, Dwight D. Stiff, et al.. (1997). A phase II trial of all- trans -retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis. Cancer Chemotherapy and Pharmacology. 39(4). 349–356. 55 indexed citations
7.
Frye, Reginald F. & Dwight D. Stiff. (1996). Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 686(2). 291–296. 58 indexed citations
8.
Garzone, Pamela D., et al.. (1995). Pain Perception and Serum Beta-Endorphin in Trauma Patients. Psychosomatics. 36(3). 276–284. 7 indexed citations
9.
Stiff, Dwight D., et al.. (1994). FK 506 (Tacrolimus) metabolism by rat liver microsomes and its inhibition by other drugs.. PubMed. 84(1). 35–46. 17 indexed citations
10.
Stiff, Dwight D., Reginald F. Frye, & Robert A. Branch. (1993). Sensitive high-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 613(1). 127–131. 17 indexed citations
11.
McAuley, James W., Patricia D. Kroboth, Dwight D. Stiff, & Ian J. Reynolds. (1993). Modulation of [3H]flunitrazepam binding by natural and synthetic progestational agents. Pharmacology Biochemistry and Behavior. 45(1). 77–83. 24 indexed citations
12.
Frye, Reginald F., et al.. (1993). Pharmacokinetics of chlorzoxazone An in vivo probe of cytochrome P4502E1 activity. 388. 1 indexed citations
13.
Stiff, Dwight D., et al.. (1992). Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. Xenobiotica. 22(1). 1–11. 39 indexed citations
14.
Pang, Songya, Lisa C. Freeman, Larry Dolan, et al.. (1992). Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.. The Journal of Clinical Endocrinology & Metabolism. 75(1). 249–253. 54 indexed citations
15.
Stiff, Dwight D., et al.. (1992). Metabolism of FK 506 in differentially induced rat liver microsomes.. PubMed. 78(1). 121–4. 11 indexed citations
16.
Stiff, Dwight D., et al.. (1992). High-Performance Liquid Chromatographic Analysis of Etoposide in Plasma Using Fluorescence Detection. Journal of Liquid Chromatography. 15(5). 863–873. 10 indexed citations
17.
Stiff, Dwight D. & Michael A. Zemaitis. (1990). Metabolism of the anticonvulsant agent zonisamide in the rat.. Drug Metabolism and Disposition. 18(6). 888–894. 38 indexed citations
18.
Stiff, Dwight D., et al.. (1983). The lack of effectiveness of (−)-epicatechin against alloxan induced diabetes in Wistar rats. Life Sciences. 33(7). 593–597. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026